Safety Advantages Over HGH No IGF-1 elevation: Studies confirm AOD-9604 does not significantly increase insulin-like growth factor levels, removing the risk of acromegaly or abnormal growth Neutral glucose impact: Unlike HGH, it does not impair insulin sensitivity or worsen blood sugar regulation Clinical Evidence In a randomized controlled trial on obese subjects, AOD-9604 was well tolerated with no significant difference in adverse events compared to placebo AOD-9604 vs Other Weight Loss Therapeutics While AOD-9604 is unique as a peptide fragment of HGH, it sits within a broader landscape of weight loss interventions
Specific Applications in Skincare and Hair Treatment Anti-Aging Formulations In anti-aging skincare, both GHK-Cu and AHK-Cu offer significant benefits, but their applications may differ based on specific aging concerns
I'm a client and I have lost 24 lbs
In a patient with normal B12 status, injecting more of it does not create surplus energy or burn fat
It also boosts energy, helping to increase activity levels, which is often a concern for many patients